Navigation Links
Bill and Melinda Gates Call for New Global Commitment to Chart a Course for Malaria Eradication
Date:10/17/2007

New Resources and Scientific Progress Help Pave the Way Toward Malaria

Eradication

U.S. Presidential Candidates Urged to Sustain and Expand President's

Malaria Initiative

SEATTLE, Oct. 17 /PRNewswire-USNewswire/ -- Bill and Melinda Gates today called on global leaders to embrace "an audacious goal - to reach a day when no human being has malaria, and no mosquito on earth is carrying it." They delivered the call to action at a forum of 300 leading malaria scientists and policymakers from around the world.

"Advances in science and medicine, promising research, and the rising concern of people around the world represent an historic opportunity not just to treat malaria or to control it - but to chart a long-term course to eradicate it," said Melinda Gates.

Every year, malaria kills more than one million people, most of them children. A malaria eradication campaign in the 1950s and 1960s collapsed because of declining donor funding and growing resistance to drugs and pesticides. Malaria programs since then have focused on reducing, not ending, the burden of malaria.

"We have a real chance to build the partnerships, generate the political will, and develop the scientific breakthroughs we need to end this disease," said Bill Gates. "We will not stop working until malaria is eradicated."

New Malaria Partnerships, Resources Achieving Large-Scale Success

Bill Gates noted that "a rush of new actors" - such as the Global Fund to Fight AIDS, Tuberculosis, and Malaria; the World Bank's Malaria Booster Program; and the U.S. President's Malaria Initiative - are bringing new energy and resources to the global effort to control malaria. Together, these initiatives have committed $3.6 billion to malaria control, and will reach more than 70 countries.

Gates also commended African countries that have undertaken aggressive, comprehensive malaria control programs. In particular, he praised Zambia's malaria program as an "inspiring example of a nationally-coordinated effort."

A new UNICEF report released at the forum documents the impressive progress of recent malaria control efforts. For example, the report shows that:

-- The annual supply of insecticide-treated bednets to prevent malaria has

more than doubled in recent years, from 30 million nets in 2004 to 63

million nets in 2006.

-- Global procurement of artemisinin combination therapies, the most

effective treatment for malaria, grew from 3 million doses in 2003 to

100 million in 2006.

To help build on this progress, Mr. and Mrs. Gates called on U.S. presidential candidates to commit to supporting the President's Malaria Initiative, a $1.2 billion effort launched by President Bush in 2005. Mr. Gates said, "If you win this office, you will inherit a record commitment to fighting malaria. The world needs you to sustain it and enhance it. Malaria will never be eradicated without the full support of the President of the United States."

Research Progress on New Vaccines, Drugs, and Insecticides

Mr. Gates cited the "extraordinary breadth of research underway in medicines, vaccines, and other control tools" as another reason for new optimism in the malaria fight. Examples of recent scientific progress by Gates Foundation grantees include the following:

-- Vaccines: New study results from the PATH Malaria Vaccine Initiative,

published today by The Lancet, show that the experimental malaria

vaccine RTS,S is safe and may significantly reduce risk of malaria

infection in infants. In the study of 200 infants, the vaccine

reduced new infections by 65% over three-and-a-half months. A large-

scale Phase III trial of the vaccine will begin next year in 10

African trial sites.

-- Medicines: The Medicines for Malaria Venture, which is researching

treatments to overcome resistance to existing drugs, has developed the

largest malaria drug portfolio in history, and expects regulatory

approval next year for an improved treatment for children.

-- Mosquito control: The Innovative Vector Control Consortium is

developing new and improved insecticides to control the mosquitoes

that transmit malaria.

New vaccines, medicines, and insecticides will help "break the cycle of transmission and eradicate the disease," said Mrs. Gates. "Both private industry and public research institutions must continue to invest in new tools in order to make malaria eradication possible."

Mr. and Mrs. Gates delivered the remarks at a meeting comprised of malaria researchers, global health leaders, policy experts, and government officials from around the world, taking place October 16-18 at the Sheraton Hotel in Seattle. Selected sessions of the meeting will be webcast at http://www.kaisernetwork.org/healthcast/malariaforum2007.

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people's health, and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people, especially those with the fewest resources, have access to the opportunities they need to succeed in school and life. Based in Seattle, the foundation is led by CEO Patty Stonesifer and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.


'/>"/>
SOURCE Bill and Melinda Gates Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Bill Gates to Fund ?28m for Malaria researc
2. Bill Gates Takes Personal Interest in AIDS Program
3. Dr.Tadataka Yamada Designated to open Gates for Global Health Program
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Gates Foundation to donate USD 104 million to TB Alliance
6. Division Among Delegates To Dilute UNs AIDS Plans: Activists
7. Bill Gates Clarifies that his Decision to Focus on Charity was Personal
8. Gates Foundation Adopts Fight against Encephalitis
9. Clinton, Gates Highlight Treatment, Discrimination of AIDS
10. A Synthetic Molecule Instigates Cancer Cells To Self-Harm
11. $68 million aid pours in from Gates Foundation to fight tropical diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... ... Celiac Association (CCA), is pleased to announce the launch of the GFCP ... articles, recipes, and more. The purpose of the GFCP Scoop site ...
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the ... of funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... base and accelerate its technology and product roadmap. , “Jvion is ...
(Date:4/29/2016)... ... April 29, 2016 , ... CURE ... entirely on patients with cancer, today announced that Lynne Malestic, RN, of Eisenhower ... 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors nurses who have ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... to promote their animal line of probiotics, Petbiotics ™, as they fondly ... turnout of animal rescue groups networking for their non-profit organizations. Animal rescues across ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016  While Abbott,s announced purchase of ... valve repair and stent business, healthcare research firm ... more firmly into patient monitoring.  Kalorama said that ... device areas, with double-digit growth expected the next ... Advanced Remote Patient Monitoring . Abbott Laboratories ...
(Date:4/28/2016)... 28, 2016 ... Phillips und Stephen Schmidt ... ArisGlobal®, ein führender Anbieter cloudbasierter Softwarelösungen ... bekannt, dass neue Führungskräfte zum Team Sicherheit ... die vielfältige Erfahrungen mitbringen.  Dies wird die ...
(Date:4/28/2016)... April 28, 2016 , Net Sales of ... basis over the prior year period, and an increase of ... , Diluted EPS for the first quarter were $0.52 reported, ... $2.00 adjusted, an increase of 29.9% over the prior year ... adjusted earnings guidance for 2016 Zimmer Biomet Holdings, ...
Breaking Medicine Technology: